Replimune Group, Inc (REPL) insider trading

Every open-market stock purchase and sale by Replimune Group, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Baker Bros. Advisors LP (Insider) bought $33M in the last 90 days.
  • Sushil Patel (CEO) and 3 others sold $1M in the last 90 days.

Last 12 months: insiders bought $33M (1 buy) and sold $1.9M (17 sales). Last close $11.72 on Oct 21, 2026.

Recent REPL insider trades

DateInsiderTradeValue
Aug 20, 2026Philip Astley-Sparke (Director)Sold (not open market)—
Aug 17, 2026Emily Luisa Hill (CFO)Sold$132K
Aug 11, 2026Baker Bros. Advisors LP (Insider)Bought$31.5M
Aug 11, 2026Baker Bros. Advisors LP (Insider)Bought$1.5M
Aug 10, 2026Sushil Patel (CEO)Sold$510K
Aug 10, 2026Emily Luisa Hill (CFO)Sold$148K
Aug 10, 2026Konstantinos Xynos (C-suite exec)Sold$148K
Aug 10, 2026Andrew Schwendenman (C-suite exec)Sold$99K
Jun 1, 2026Christopher Sarchi (C-suite exec)Sold$111K
May 18, 2026Sushil Patel (CEO)Sold$190K
May 18, 2026Philip Astley-Sparke (Director)Sold$89.7K
May 18, 2026Konstantinos Xynos (C-suite exec)Sold$71.2K
May 18, 2026Christopher Sarchi (C-suite exec)Sold$43.8K
May 18, 2026Andrew Schwendenman (C-suite exec)Sold$40.1K
May 18, 2026Emily Luisa Hill (CFO)Sold$39.7K
Apr 2, 2026Christopher Sarchi (C-suite exec)Sold$52.1K
Apr 1, 2026Konstantinos Xynos (C-suite exec)Bought (not open market)—
Apr 1, 2026Konstantinos Xynos (C-suite exec)Bought (not open market)—
Apr 1, 2026Christopher Sarchi (C-suite exec)Bought (not open market)—
Apr 1, 2026Joseph P Slattery (Director)Bought (not open market)—
Apr 1, 2026Christopher Sarchi (C-suite exec)Bought (not open market)—
Apr 1, 2026Philip Astley-Sparke (Director)Bought (not open market)—
Apr 1, 2026Philip Astley-Sparke (Director)Bought (not open market)—
Apr 1, 2026Baker Bros. Advisors LP (Insider)Bought (not open market)—
Apr 1, 2026Madhavan Balachandran (Director)Bought (not open market)—

Who's trading REPL

Get free alerts when an insider at Replimune Group, Inc files a new trade →